4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-026838
Chief Executive Officer sold 8,800 shares at an average $42.46 ($373,659)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-04-26 | Sale | −3,300 | $41.99 | $138,567 | 194,378 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-04-26 | Sale | −1,100 | $42.60 | $46,860 | 193,278 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-04-27 | Sale | −3,900 | $42.63 | $166,257 | 189,378 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-04-27 | Sale | −500 | $43.95 | $21,975 | 188,878 | I: show line 4 in the form |
| Open-market sales · 8,800 sh · avg $42.46 · $373,659 | |||||||
Loading xslF345X03/doc4.xml…